← Back to Search

3-Point Tracking Device for Respiratory Insufficiency

N/A

Recruiting

Led By Ryan Carroll, MD, MPH

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients 28-days to 17-years of age who do not have respiratory distress

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up over 30 - 7200 minutes

Awards & highlights

Study Summary

This trial is testing a 3-point tracking device to see if it can help guide respiratory support interventions by providing information on thoracoabdominal asynchrony (TAA).

Who is the study for?

This trial is for children and teenagers from 28 days to 17 years old, both with and without respiratory distress. It's not suitable for those who have injuries or conditions that would interfere with attaching a motion-sensing device to their chest and abdomen.Check my eligibility

What is being tested?

The study is testing a new device designed to monitor thoracoabdominal asynchrony (TAA) - when the chest and belly don't move in sync during breathing, which can indicate respiratory distress. The goal is to see if this device can help clinicians make decisions about providing or adjusting respiratory support.See study design

What are the potential side effects?

Since this trial involves monitoring with a non-invasive device, there are minimal expected side effects. However, some participants might experience discomfort or skin irritation where the sensors attach.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 28 days and 17 years old and do not have trouble breathing.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ over 30 - 7200 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~over 30 - 7200 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and over 30 - 7200 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Objectively determine thoracoabdominal asynchrony

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Respiratory insufficiency or distressActive Control1 Intervention

Patients demonstrating respiratory insufficiency or distress.

Group II: No respiratory insufficiency or distress.Placebo Group1 Intervention

Patients NOT demonstrating respiratory insufficiency or distress.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,933 Previous Clinical Trials

13,198,461 Total Patients Enrolled

17 Trials studying Respiratory Insufficiency

177,597 Patients Enrolled for Respiratory Insufficiency

Ryan Carroll, MD, MPHPrincipal Investigator - Massachusetts General Hospital

Massachusetts General Hospital

Ben Gurion University Of The Negev (Medical School)

Northwestern University Medical Sch (Residency)

Media Library

Objectively monitoring thoracoabdominal asynchrony Clinical Trial Eligibility Overview. Trial Name: NCT04626154 — N/A

Respiratory Insufficiency Research Study Groups: No respiratory insufficiency or distress., Respiratory insufficiency or distress

Respiratory Insufficiency Clinical Trial 2023: Objectively monitoring thoracoabdominal asynchrony Highlights & Side Effects. Trial Name: NCT04626154 — N/A

Objectively monitoring thoracoabdominal asynchrony 2023 Treatment Timeline for Medical Study. Trial Name: NCT04626154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for enrollment in this clinical experiment?

"Affirmative. Clinicaltrials.gov attests that this medical trial is actively recruiting participants, with 20 patients sought from a single site since its launch on October 16th 2020 and last update on August 8th 2022."

Answered by AI

How many participants are involved in this research study?

"Indeed, the clinicaltrial.gov website conveys that this trial is accepting participants. Originally published on October 16th 2020, enrollment has since been updated as of August 8th 2022 and now seeks 20 candidates from one site."

Answered by AI

Do I meet the criteria to participate in this research?

"To qualify for this trial, prospective participants must have respiratory failure and should be between 28 days to 17 years old. The medical team is hoping to accept 20 individuals into the study."

Answered by AI

Is participation restricted to those within a certain age range, or are all adults welcome?

"To be included in this trial, potential participants must fall between 28 days and 17 years of age. Notably, there are 30 studies dedicated to minors and 155 aimed at the elderly population."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Thoracoabdominal Asynchrony and Respiratory Distress

Ryan Carroll 2020. "Thoracoabdominal Asynchrony and Respiratory Distress". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04626154.